Bragar Eagel & Squire, P.C. Urges Ostin and NuScale Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines
globenewswire.com
Want to monitor VERA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VERAtrucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis.